Je was op zoek naar: medullær tværsnitslæsion (Deens - Engels)

medullær
medullary

kliniske data i medullær thyroideacancer
clinical data in medullary thyroid cancer

cerebro-medullær malformation arnold chiari type i
chiari malformation type i

cometriq kan sinke eller stoppe væksten af medullær thyroideacancer.
cometriq may slow or stop the growth of medullary thyroid cancer.

det ses hos 8% af personer, som tager caprelsa mod medullær thyreoideacancer.
they are seen in 8% of people taking caprelsa for medullary thyroid cancer.

virkning med cabozantinib blev observeret hos patienter med medullær thyroideacancer med vildt- type eller mutant ret.
efficacy with cabozantinib was observed in medullary thyroid cancer patients with wild-type or mutant ret.

caprelsa anvendes til behandling af medullær thyreoideacancer, som ikke kan fjernes med kirurgi, eller som har bredt sig til andre dele af kroppen.
caprelsa is used to treat medullary thyroid cancer that cannot be removed by surgery or has spread to other parts of the body.

det anvendes til behandling af voksne med medullær thyroideacancer, en kræfttype, som udgår fra de celler i skjoldbruskkirtlen, der producerer hormonet calcitonin.
it is used to treat adults with medullary thyroid cancer, a type of cancer originating in the cells in the thyroid gland that produce the hormone calcitonin.

mineralisering i epitelet i nyrepelvis såvel som nogen renocortical og cortico-medullær mineralisering blev iagttaget i alle grupper, især i hunner på højeste dosering.
mineralisation in the pelvic renal epithelium as well as some renal cortical and cortico-medullary rnineralisation was seen in all groups and especially in the top dose female group.

caprelsa anvendes til behandling af medullær thyreoideacancer , en form for cancer, der påvirker skjoldbruskkirtlen, og som stammer fra celler, der producerer hormonet calcitonin.
caprelsa is used to treat medullary thyroid cancer, a type of cancer affecting the thyroid gland that originates in the cells that produce the hormone calcitonin.

cometriq er et lægemiddel, der anvendes til behandling af medullær thyroideacancer, en sjælden type thyroideacancer, der ikke kan fjernes ved operation eller som har spredt sig til andre dele af kroppen.
cometriq is a medicine used to treat medullary thyroid cancer, a rare type of thyroid cancer, that cannot be removed by surgery or that has spread to other parts of the body.

der er set tilfælde af interstitial nefritis med medullær kalcifikation og kortikal atrofi hos patienter med asymptomatisk svær leukocyturi (> 100 celler/ højt styrkefelt).
cases of interstitial nephritis with medullary calcification and cortical atrophy have been observed in patients with asymptomatic severe leucocyturia (> 100 cells/ high power field).

chmp konkluderede, at caprelsa har vist sig at være effektiv i behandlingen af medullær thyreoideacancer, selv om der var usikkerhed omkring graden af effektivitet hos patienter, hvis ret- mutationsstatus er negativ eller ukendt.
the chmp concluded that caprelsa was shown to be effective in the treatment of medullary thyroid cancer although there were uncertainties about the size of the benefit in patients whose ret mutation status is negative or unknown.

brown-séquards medullære tværsnitssyndrom
brown-sequard's syndrome